Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Ret Proto-Oncogene anticorps

Cet anticorps Lapin Polyclonal détecte spécifiquement Ret Proto-Oncogene dans WB. Il présente une réactivité envers Humain et a été mentionné dans 4+ publications.
N° du produit ABIN1882126

Aperçu rapide pour Ret Proto-Oncogene anticorps (ABIN1882126)

Antigène

Voir toutes Ret Proto-Oncogene (RET) Anticorps
Ret Proto-Oncogene (RET)

Reactivité

  • 170
  • 94
  • 70
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 175
  • 44
  • 2
  • 2
  • 1
  • 1
Lapin

Clonalité

  • 173
  • 52
Polyclonal

Conjugué

  • 92
  • 15
  • 11
  • 9
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Cet anticorp Ret Proto-Oncogene est non-conjugé

Application

  • 169
  • 83
  • 65
  • 65
  • 54
  • 25
  • 18
  • 17
  • 14
  • 12
  • 10
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RB17715
  • Purification

    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

    Immunogène

    This RET antibody is generated from rabbits immunized with His fusion protein of human RET.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Date de péremption

    6 months
  • Siqueira, Romitti, da Rocha, Ceolin, Meotti, Estivalet, Puñales, Maia: "The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma." dans: Endocrine-related cancer, Vol. 17, Issue 4, pp. 953-63, (2010) (PubMed).

    Gockel, Schumacher, Gockel, Lang, Haaf, Nöthen: "Achalasia: will genetic studies provide insights?" dans: Human genetics, Vol. 128, Issue 4, pp. 353-64, (2010) (PubMed).

    Kim, Jung, Lim, Sung, Whang, Jo, Lee, Shin, Kim, Ryu, Kim: "A study of RET proto-oncogene polymorphisms in association with lung cancer risk in the Korean population." dans: Anticancer research, Vol. 30, Issue 9, pp. 3621-7, (2010) (PubMed).

    Pacini, Castagna, Cipri, Schlumberger: "Medullary thyroid carcinoma." dans: Clinical oncology (Royal College of Radiologists (Great Britain)), Vol. 22, Issue 6, pp. 475-85, (2010) (PubMed).

  • Antigène

    Ret Proto-Oncogene (RET)

    Autre désignation

    RET

    Sujet

    This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed.

    Poids moléculaire

    124319

    NCBI Accession

    NP_065681, NP_066124

    UniProt

    P07949

    Pathways

    Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Vous êtes ici:
Chat with us!